Martínez-Muñoz Alberto, Bello Martiniano, Romero-Castro Aurelio, Rodríguez-Fonseca Rolando Alberto, Rodrigues João, Sánchez-Espinosa Víctor Armando, Correa-Basurto José
Laboratorio de Modelado Molecular y Bioinformática de la Escuela Superior de Medicina, Instituto Politécnico Nacional, México, Plan de San Luis Y Diaz Mirón S/N, Col. Casco de Santo Tomas, Ciudad de México, CP: 11340, Mexico.
Laboratorio de Modelado Molecular y Bioinformática de la Escuela Superior de Medicina, Instituto Politécnico Nacional, México, Plan de San Luis Y Diaz Mirón S/N, Col. Casco de Santo Tomas, Ciudad de México, CP: 11340, Mexico.
J Mol Graph Model. 2017 Sep;76:330-341. doi: 10.1016/j.jmgm.2017.07.017. Epub 2017 Jul 19.
Dendrimers are synthetic macromolecules with a highly-branched structure and high concentration of surface groups. Among dendrimers, Poly(amidoamine) (PAMAM) has received substantial attention as a novel drug carrier and delivery system. Depending on the generation and type of terminal groups, dendrimer toxicity could change and include cytotoxicity. Although PAMAM is water soluble, molecular modeling of the dendrimer-drug complex is considered challenging for exploring the conformational mobility of dendrimers and atomic specific interactions during the dendrimer-drug association. However, conventional protocols for predicting binding affinities have been designed for small protein molecules or protein-protein complexes that can be applied to study the dendrimer-drug association. In this work, we performed docking calculations for a set of 94 previously reported compounds on PAMAM of fourth generation (G4-PAMAM) to select six compounds, cromoglicic acid (CRO) - a mast cell stabilizer, Fusidic acid (FUS) - a bacteriostatic antibiotic, and Methotrexate (MTX) - a chemotherapy agent and immune system suppressant, which have the highest affinities for G4-PAMAM, and Lidocaine (LDC) - used to numb tissue in a specific area and for ventricular tachycardia treatment, Metoprolol (MET) - a β receptor blocker, and Pindolol (PIN) - a β blocker, which have the lowest affinities for the G4-PAMAM dendrimer, to perform MD simulations combined with the molecular mechanics generalized/Poisson-Boltzmann surface area MMGBSA/MMPBSA approach to investigate the interactions of generating 4 charge-neutral, charge-basic and charge-acid G4-PAMAM dendrimers. In addition, to validate these theoretical G4-PAMAM-drug complexes, the complexes were experimentally conjugated to determine their stability in aqueous solubility studies immediately and over one year. Our results show that among the different commercial drugs, both charged and neutral PAMAM have the most favorable binding free energies for CRO, MTX, and FUS, which appears to be due to a complex counterbalance of electrostatics and van der Waals interactions. These theoretical and aqueous solubility studies supported the high affinity of methotrexate for the G4-PAMAM-drug due to its carboxyl and aryl moieties that favor its accommodation by noncovalent interactions.
树枝状聚合物是具有高度分支结构和高浓度表面基团的合成大分子。在树枝状聚合物中,聚(酰胺胺)(PAMAM)作为一种新型药物载体和递送系统受到了广泛关注。根据末端基团的代数和类型,树枝状聚合物的毒性可能会发生变化,包括细胞毒性。尽管PAMAM是水溶性的,但对于探索树枝状聚合物的构象流动性以及树枝状聚合物与药物结合过程中的原子特异性相互作用而言,树枝状聚合物 - 药物复合物的分子建模被认为具有挑战性。然而,用于预测结合亲和力的传统协议是为小分子蛋白质或蛋白质 - 蛋白质复合物设计的,可用于研究树枝状聚合物与药物的结合。在这项工作中,我们对一组94种先前报道的化合物在第四代PAMAM(G4 - PAMAM)上进行对接计算,以选择六种化合物,色甘酸(CRO) - 一种肥大细胞稳定剂,夫西地酸(FUS) - 一种抑菌抗生素,以及甲氨蝶呤(MTX) - 一种化疗药物和免疫系统抑制剂,它们对G4 - PAMAM具有最高的亲和力,还有利多卡因(LDC) - 用于使特定区域的组织麻木和治疗室性心动过速,美托洛尔(MET) - 一种β受体阻滞剂,以及吲哚洛尔(PIN) - 一种β阻滞剂,它们对G4 - PAMAM树枝状聚合物具有最低的亲和力,以结合分子力学广义/泊松 - 玻尔兹曼表面积MMGBSA/MMPBSA方法进行分子动力学(MD)模拟,以研究生成的4种电荷中性、电荷碱性和电荷酸性G4 - PAMAM树枝状聚合物的相互作用。此外,为了验证这些理论上的G4 - PAMAM - 药物复合物,通过实验将这些复合物共轭,以立即和在一年时间内确定它们在水溶性研究中的稳定性。我们的结果表明,在不同的市售药物中,带电和中性的PAMAM对CRO、MTX和FUS都具有最有利的结合自由能,这似乎是由于静电和范德华相互作用的复杂平衡。这些理论和水溶性研究支持了甲氨蝶呤因其羧基和芳基部分通过非共价相互作用有利于其容纳而对G4 - PAMAM - 药物具有高亲和力。